1.Bloodstream infection in lung tumor patient caused by Bacteroides unifor-mis:a case report
Fengxia WANG ; Cuizhu CHEN ; Yinjian MA ; Bing JI ; Baosong LI
Chinese Journal of Infection Control 2025;24(10):1494-1496
Bacteroides uniformis(B.uniformis)is an obligate anaerobic Gram-negative bacteria,it belongs to Bacieroides spp..It is an important component of the normal gut microbiota in human body and rarely causes op-portunistic infection in clinical practice.Currently,there is no consensus on the clinical characteristics,diagnosis,treatment,and prognosis of infection caused by B.uniformis,and the resistance of anaerobic bacteria is difficult to be detected.This article reports a case of a lung tumor patient who developed diarrhea and bloodstream infection due to B.uniformis after chemotherapy.After empirical anti-infective treatment with cefoperazone/sulbactam,the pa-tient recovered and was discharged from hospital.This paper aims to improve clinical understanding on infection caused by opportunistic pathogens in the gut,and provide reference for timely diagnosis and effective treatment.
2.Bloodstream infection in lung tumor patient caused by Bacteroides unifor-mis:a case report
Fengxia WANG ; Cuizhu CHEN ; Yinjian MA ; Bing JI ; Baosong LI
Chinese Journal of Infection Control 2025;24(10):1494-1496
Bacteroides uniformis(B.uniformis)is an obligate anaerobic Gram-negative bacteria,it belongs to Bacieroides spp..It is an important component of the normal gut microbiota in human body and rarely causes op-portunistic infection in clinical practice.Currently,there is no consensus on the clinical characteristics,diagnosis,treatment,and prognosis of infection caused by B.uniformis,and the resistance of anaerobic bacteria is difficult to be detected.This article reports a case of a lung tumor patient who developed diarrhea and bloodstream infection due to B.uniformis after chemotherapy.After empirical anti-infective treatment with cefoperazone/sulbactam,the pa-tient recovered and was discharged from hospital.This paper aims to improve clinical understanding on infection caused by opportunistic pathogens in the gut,and provide reference for timely diagnosis and effective treatment.
3.Non-Ischemic, Non-Hypoxic Myocardial Injury, and Long-Term Mortality in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
Fajiu LI ; Xijie ZHU ; Ziyang ZHU ; Yinjian YANG ; Zhuang TIAN ; Duolao WANG ; Shi CHEN ; Xiaoyan GAO ; Yalin XU ; Bo ZHANG ; Wei YU ; Min LIU ; Xiqi XU ; Chenghong LI ; Shuyang ZHANG
Cardiology Discovery 2022;02(2):77-82
Objective::Cardiac damage is commonly reported in patients with coronavirus disease 2019 (COVID-19) but its prevalence and impact on the long-term survival of patients remain uncertain. This study aimed to explore the prevalence of myocardial injury and assess its prognostic value in patients with COVID-19.Methods::A single-center, retrospective cohort study was performed at the Affiliated Hospital of Jianghan University. Data from 766 patients with confirmed COVID-19 who were hospitalized from December 27, 2019 to April 25, 2020 were collected. Demographic, clinical, laboratory, electrocardiogram, treatment data and all-cause mortality during follow-up were collected and analyzed.Results::Of the 766 patients with moderate to critically ill COVID-19, 86 (11.2%) died after a mean follow-up of 72.8 days. Myocardial injury occurred in 94 (12.3%) patients. The mortality rate was 64.9% (61/94) and 3.7% (25/672) in patients with and without myocardial injury, respectively. Cox regression showed that myocardial injury was an independent risk factor for mortality (hazard ratio: 8.76, 95% confidence interval: 4.76-16.11, P < 0.001). Of the 90 patients with myocardial injury with electrocardiogram results, sinus tachycardia was present in 29, bundle branch block in 26, low voltage in 10, and abnormal T-wave in 53. Conclusions::COVID-19 not only involves pneumonia but also cardiac damage. Myocardial injury is a common complication and an independent risk factor for mortality in COVID-19 patients.
4.Non-Ischemic, Non-Hypoxic Myocardial Injury, and Long-Term Mortality in Patients with Coronavirus Disease 2019: A Retrospective Cohort Study
Fajiu LI ; Xijie ZHU ; Ziyang ZHU ; Yinjian YANG ; Zhuang TIAN ; Duolao WANG ; Shi CHEN ; Xiaoyan GAO ; Yalin XU ; Bo ZHANG ; Wei YU ; Min LIU ; Xiqi XU ; Chenghong LI ; Shuyang ZHANG
Cardiology Discovery 2022;02(2):77-82
Objective::Cardiac damage is commonly reported in patients with coronavirus disease 2019 (COVID-19) but its prevalence and impact on the long-term survival of patients remain uncertain. This study aimed to explore the prevalence of myocardial injury and assess its prognostic value in patients with COVID-19.Methods::A single-center, retrospective cohort study was performed at the Affiliated Hospital of Jianghan University. Data from 766 patients with confirmed COVID-19 who were hospitalized from December 27, 2019 to April 25, 2020 were collected. Demographic, clinical, laboratory, electrocardiogram, treatment data and all-cause mortality during follow-up were collected and analyzed.Results::Of the 766 patients with moderate to critically ill COVID-19, 86 (11.2%) died after a mean follow-up of 72.8 days. Myocardial injury occurred in 94 (12.3%) patients. The mortality rate was 64.9% (61/94) and 3.7% (25/672) in patients with and without myocardial injury, respectively. Cox regression showed that myocardial injury was an independent risk factor for mortality (hazard ratio: 8.76, 95% confidence interval: 4.76-16.11, P < 0.001). Of the 90 patients with myocardial injury with electrocardiogram results, sinus tachycardia was present in 29, bundle branch block in 26, low voltage in 10, and abnormal T-wave in 53. Conclusions::COVID-19 not only involves pneumonia but also cardiac damage. Myocardial injury is a common complication and an independent risk factor for mortality in COVID-19 patients.
5.The role of hydrogen sulfide and cystathionine-gamma-lyase in allergic rhinitis guinea pigs.
Shaoqing YU ; Ruxin ZHANG ; Yinjian CHEN ; Jianqiu CHEN ; Geping WU ; Zhenyang GONG ; Jiangfeng TANG ; Genhong LI ; Chunsheng ZHU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2008;22(14):654-657
OBJECTIVE:
To study the change of endogenous hydrogen sulfide (hydrogen sulfide, H2S) and its rate-limiting enzyme Cystathionine-gamma-lyase (CSE) in allergic rhinitis through guinea pigs with intervention treatment.
METHOD:
Twenty-four guinea pigs were divide into 4 groups at random, one group were models of allergic rhinitis (AR) which were established by using ovalbumin, the second group were treated with NaHS after sensitized, the third group were treated with Propargylglycine (PPG) which was suppression of CSE after sensitized, and the last group were treated with saline for control. The concentration of eotaxin of nasal lavage and H2S in plasma were recorded, and then the expression of CSE in nasal mucosa was determined by real-time fluorescence RT-PCR.
RESULT:
The concentration of eotaxin in nasal lavage of sensitized group were higher than those of control (P < 0.01), and concentration of H2S in plasma and expression of CSE in nasal mucosa were lower than control (P < 0.05). The concentration of eotaxin decreased when treated with NaHS and increased when treated with PGG (P < 0.05). Level of H2S in plasma and expression of CSE increased when treated with NaHS and decreased when treated with PGG (P < 0.05), and the level of H2S was positive linear correlate with the expression of CSE.
CONCLUSION
Endogenous H2S perhaps plays a significant role in the pathogenesis of allergic rhinitis, and it was mainly regulated by CSE.
Animals
;
Cystathionine gamma-Lyase
;
metabolism
;
Guinea Pigs
;
Hydrogen Sulfide
;
metabolism
;
Male
;
Nasal Mucosa
;
metabolism
;
Rhinitis
;
metabolism

Result Analysis
Print
Save
E-mail